TY - JOUR AU - Escudier, B. AU - Porta, C. AU - Schmidinger, M. AU - Rioux-Leclercq, N. AU - Bex, A. PY - 2016 DA - 2016// TI - Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw328 DO - 10.1093/annonc/mdw328 ID - Escudier2016 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - Oudard, S. AU - Hutson, T. E. AU - Porta, C. AU - Bracarda, S. PY - 2010 DA - 2010// TI - Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25219 DO - 10.1002/cncr.25219 ID - Motzer2010 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - Tomczak, P. AU - Hutson, T. E. AU - Michaelson, M. D. AU - Negrier, S. PY - 2013 DA - 2013// TI - Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70093-7 DO - 10.1016/S1470-2045(13)70093-7 ID - Motzer2013 ER - TY - JOUR AU - Mitchell, A. P. AU - Harrison, M. R. AU - Walker, M. S. AU - George, D. J. AU - Abernethy, A. P. AU - Hirsch, B. R. PY - 2015 DA - 2015// TI - Clinical trial participants with metastatic renal cell carcinoma differ from patients treated in real-world practice JO - J Oncol Pract VL - 11 UR - https://doi.org/10.1200/JOP.2015.004929 DO - 10.1200/JOP.2015.004929 ID - Mitchell2015 ER - TY - JOUR AU - Poprach, A. AU - Bortlicek, Z. AU - Buchler, T. AU - Melichar, B. AU - Lakomy, R. AU - Vyzula, R. PY - 2012 DA - 2012// TI - Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-012-0286-9 DO - 10.1007/s12032-012-0286-9 ID - Poprach2012 ER - TY - JOUR AU - Poprach, A. AU - Pavlik, T. AU - Melichar, B. AU - Puzanov, I. AU - Dusek, L. AU - Bortlicek, Z. PY - 2012 DA - 2012// TI - Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds145 DO - 10.1093/annonc/mds145 ID - Poprach2012 ER - TY - JOUR AU - Buchler, T. AU - Klapka, R. AU - Melichar, B. AU - Brabec, P. AU - Dusek, L. AU - Vyzula, R. AU - Abrahamova, J. PY - 2012 DA - 2012// TI - Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma--data from the Czech registry JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr065 DO - 10.1093/annonc/mdr065 ID - Buchler2012 ER - TY - JOUR AU - Buchler, T. AU - Pavlik, T. AU - Bortlicek, Z. AU - Poprach, A. AU - Vyzula, R. AU - Abrahamova, J. AU - Melichar, B. PY - 2012 DA - 2012// TI - Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-012-0293-x DO - 10.1007/s12032-012-0293-x ID - Buchler2012 ER - TY - JOUR AU - Buchler, T. AU - Bortlicek, Z. AU - Poprach, A. AU - Kubackova, K. AU - Kiss, I. AU - Zemanova, M. PY - 2014 DA - 2014// TI - Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: a registry-based analysis JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2013.12.007 DO - 10.1016/j.urolonc.2013.12.007 ID - Buchler2014 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Trotti, A. AU - Colevas, A. D. AU - Setser, A. AU - Rusch, V. AU - Jaques, D. AU - Budach, V. PY - 2003 DA - 2003// TI - CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment JO - Semin Radiat Oncol VL - 13 UR - https://doi.org/10.1016/S1053-4296(03)00031-6 DO - 10.1016/S1053-4296(03)00031-6 ID - Trotti2003 ER - TY - JOUR AU - Bergmann, L. AU - Kube, U. AU - Doehn, C. AU - Steiner, T. AU - Goebell, P. J. AU - Kindler, M. PY - 2015 DA - 2015// TI - Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1309-7 DO - 10.1186/s12885-015-1309-7 ID - Bergmann2015 ER - TY - JOUR AU - Eichelberg, C. AU - Vervenne, W. L. AU - De Santis, M. AU - Fischer von Weikersthal, L. AU - Goebell, P. J. AU - Lerchenmüller, C. PY - 2015 DA - 2015// TI - SWITCH: a randomised, sequential, open-label study to evaluate the efficacy and safety of sorafenib-sunitinib versus sunitinib-sorafenib in the treatment of metastatic renal cell cancer JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2015.04.017 DO - 10.1016/j.eururo.2015.04.017 ID - Eichelberg2015 ER - TY - JOUR AU - Pal, S. K. AU - Signorovitch, J. E. AU - Reichmann, W. M. AU - Li, N. AU - Koo, V. AU - Liu, Z. PY - 2016 DA - 2016// TI - Real-world effectiveness of everolimus subsequent to different first targeted therapies for the treatment of metastatic renal cell carcinoma: synthesis of retrospective chart reviews JO - Clin Genitourin Cancer VL - 14 UR - https://doi.org/10.1016/j.clgc.2015.11.011 DO - 10.1016/j.clgc.2015.11.011 ID - Pal2016 ER - TY - JOUR AU - Ko, J. J. AU - Xie, W. AU - Kroeger, N. AU - Lee, J. L. AU - Rini, B. I. AU - Knox, J. J. PY - 2015 DA - 2015// TI - The international metastatic renal cell carcinoma database consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71222-7 DO - 10.1016/S1470-2045(14)71222-7 ID - Ko2015 ER - TY - JOUR AU - Harrison, M. R. AU - Hirsch, B. R. AU - George, D. J. AU - Walker, M. S. AU - Chen, C. AU - Korytowsky, B. PY - 2014 DA - 2014// TI - Real-world outcomes in metastatic renal cell carcinoma: insights from a joint community-academic registry JO - J Oncol Pract VL - 10 UR - https://doi.org/10.1200/JOP.2013.001180 DO - 10.1200/JOP.2013.001180 ID - Harrison2014 ER - TY - JOUR AU - Motzer, R. J. AU - Barrios, C. H. AU - Kim, T. M. AU - Falcon, S. AU - Cosgriff, T. AU - Harker, W. G. PY - 2014 DA - 2014// TI - Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.6911 DO - 10.1200/JCO.2013.54.6911 ID - Motzer2014 ER - TY - JOUR AU - Busch, J. AU - Seidel, C. AU - Kempkensteffen, C. AU - Johannsen, M. AU - Wolff, I. AU - Hinz, S. PY - 2011 DA - 2011// TI - Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.07.037 DO - 10.1016/j.eururo.2011.07.037 ID - Busch2011 ER - TY - JOUR AU - Iacovelli, R. AU - Carteni, G. AU - Sternberg, C. N. AU - Milella, M. AU - Santoni, M. AU - Di Lorenzo, G. PY - 2013 DA - 2013// TI - Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2013.02.032 DO - 10.1016/j.ejca.2013.02.032 ID - Iacovelli2013 ER - TY - JOUR AU - Heng, D. Y. AU - Signorovitch, J. AU - Swallow, E. AU - Li, N. AU - Zhong, Y. AU - Qin, P. PY - 2014 DA - 2014// TI - Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: a systematic review and meta-analysis of real-world observational studies JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0114264 DO - 10.1371/journal.pone.0114264 ID - Heng2014 ER - TY - JOUR AU - Choueiri, T. K. AU - Escudier, B. AU - Powles, T. AU - Mainwaring, P. N. AU - Rini, B. I. AU - Donskov, F. PY - 2015 DA - 2015// TI - Cabozantinib versus everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510016 DO - 10.1056/NEJMoa1510016 ID - Choueiri2015 ER - TY - JOUR AU - Davis, I. D. AU - Xie, W. AU - Pezaro, C. AU - Donskov, F. AU - Wells, J. C. AU - Agarwal, N. PY - 2017 DA - 2017// TI - Efficacy of second-line targeted therapy for renal cell carcinoma according to change from baseline in international metastatic renal cell carcinoma database consortium prognostic category JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.09.047 DO - 10.1016/j.eururo.2016.09.047 ID - Davis2017 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. AU - Srinivas, S. PY - 2015 DA - 2015// TI - Nivolumab versus everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - JOUR AU - Al-Marrawi, M. Y. AU - Rini, B. I. AU - Harshman, L. C. AU - Bjarnason, G. AU - Wood, L. AU - Vaishampayan, U. PY - 2013 DA - 2013// TI - The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients JO - Target Oncol VL - 8 UR - https://doi.org/10.1007/s11523-012-0252-7 DO - 10.1007/s11523-012-0252-7 ID - Al-Marrawi2013 ER - TY - JOUR AU - Vogelzang, N. J. AU - Pal, S. K. AU - Signorovitch, J. E. AU - Reichmann, W. M. AU - Li, N. AU - Yang, C. PY - 2016 DA - 2016// TI - Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review JO - Curr Med Res Opin VL - 32 UR - https://doi.org/10.1185/03007995.2016.1140028 DO - 10.1185/03007995.2016.1140028 ID - Vogelzang2016 ER - TY - JOUR AU - Albiges, L. AU - Choueiri, T. AU - Escudier, B. AU - Galsky, M. AU - George, D. AU - Hofmann, F. PY - 2015 DA - 2015// TI - A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.04.006 DO - 10.1016/j.eururo.2014.04.006 ID - Albiges2015 ER - TY - JOUR AU - Heng, D. Y. AU - Mackenzie, M. J. AU - Vaishampayan, U. N. AU - Bjarnason, G. A. AU - Knox, J. J. AU - Tan, M. H. PY - 2012 DA - 2012// TI - Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr533 DO - 10.1093/annonc/mdr533 ID - Heng2012 ER - TY - JOUR AU - Levy, A. AU - Menard, J. AU - Albiges, L. AU - Loriot, Y. AU - Di Palma, M. AU - Fizazi, K. PY - 2013 DA - 2013// TI - Second line treatment of metastatic renal cell carcinoma: the Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2013.02.003 DO - 10.1016/j.ejca.2013.02.003 ID - Levy2013 ER - TY - JOUR AU - Beisland, C. AU - Johannesen, T. B. AU - Klepp, O. AU - Axcrona, U. AU - Torgersen, K. M. AU - Kowalski, J. PY - 2017 DA - 2017// TI - Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study JO - Onco Targets Ther VL - 10 UR - https://doi.org/10.2147/OTT.S123061 DO - 10.2147/OTT.S123061 ID - Beisland2017 ER - TY - JOUR AU - Alimohamed, N. AU - Lee, J. L. AU - Srinivas, S. AU - Bjarnason, G. A. AU - Knox, J. J. AU - Mackenzie, M. J. PY - 2014 DA - 2014// TI - A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma JO - Clin Genitourin Cancer VL - 12 UR - https://doi.org/10.1016/j.clgc.2013.12.003 DO - 10.1016/j.clgc.2013.12.003 ID - Alimohamed2014 ER - TY - JOUR AU - Wagstaff, J. AU - Jones, R. AU - Hawkins, R. AU - Porfiri, E. AU - Pickering, L. AU - Bahl, A. PY - 2016 DA - 2016// TI - Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv504 DO - 10.1093/annonc/mdv504 ID - Wagstaff2016 ER -